Long-term increase in sensitivity to ketamine's behavioral effects in mice exposed to mild blast induced traumatic brain injury

Exp Neurol. 2022 Apr:350:113963. doi: 10.1016/j.expneurol.2021.113963. Epub 2021 Dec 28.

Abstract

Neurobehavioral deficits emerge in nearly 50% of patients following a mild traumatic brain injury (TBI) and may persist for months. Ketamine is used frequently as an anesthetic/analgesic and for management of persistent psychiatric complications. Although ketamine may produce beneficial effects in patients with a history of TBI, differential sensitivity to its impairing effects could make the therapeutic use of ketamine in TBI patients unsafe. This series of studies examined male C57BL/6 J mice exposed to a mild single blast overpressure (mbTBI) for indications of altered sensitivity to ketamine at varying times after injury. Dystaxia (altered gait), diminished sensorimotor gating (reduced prepulse inhibition) and impaired working memory (step-down inhibitory avoidance) were examined in mbTBI and sham animals 15 min following intraperitoneal injections of saline or R,S-ketamine hydrochloride, from day 7-16 post injury and again from day 35-43 post injury. Behavioral performance in the forced swim test and sucrose preference test were evaluated on day 28 and day 74 post injury respectively, 24 h following drug administration. Dynamic gait stability was compromised in mbTBI mice on day 7 and 35 post injury and further exacerbated following ketamine administration. On day 14 and 42 post injury, prepulse inhibition was robustly decreased by mbTBI, which ketamine further reduced. Ketamine-associated memory impairment was apparent selectively in mbTBI animals 1 h, 24 h and day 28 post shock (tested on day 15/16/43 post injury). Ketamine selectively reduced immobility scores in the FST in mbTBI animals (day 28) and reversed mbTBI induced decreases in sucrose consumption (Day 74). These results demonstrate increased sensitivity to ketamine in mice when tested for extended periods after TBI. The results suggest that ketamine may be effective for treating neuropsychiatric complications that emerge after TBI but urge caution when used in clinical practice for enhanced sensitivity to its side effects in this patient population.

Keywords: Advanced blast simulator; Antidepressant; Ketamine; Mild traumatic brain injury; Side-effect.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anesthetics, Dissociative / adverse effects
  • Anesthetics, Dissociative / pharmacology*
  • Animals
  • Ataxia / etiology
  • Ataxia / psychology
  • Behavior, Animal / drug effects*
  • Blast Injuries / psychology*
  • Brain Concussion
  • Brain Injuries, Traumatic / psychology*
  • Ketamine / adverse effects
  • Ketamine / pharmacology*
  • Lameness, Animal / chemically induced
  • Lameness, Animal / psychology
  • Male
  • Memory Disorders / etiology
  • Memory Disorders / psychology
  • Mice
  • Mice, Inbred C57BL
  • Motor Activity / drug effects
  • Prepulse Inhibition
  • Psychomotor Performance / drug effects
  • Sensory Gating / drug effects

Substances

  • Anesthetics, Dissociative
  • Ketamine